ARIAD Pharmaceuticals Inc logo

ARIA - ARIAD Pharmaceuticals Inc News Story

$23.99 0.0  0.0%

Last Trade - 15/02/17

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £142.8m
Position in Universe th / 6406

BRIEF-Ariad announces submission of marketing authorization application for Brigatinib

Mon 6th February, 2017 12:35pm
Feb 6 (Reuters) - Ariad Pharmaceuticals Inc  ARIA.O  
    * Ariad announces submission of marketing authorization 
application for Brigatinib to the European Medicines Agency 
    * FDA currently reviewing a NDA for Brigatinib filed by 
co,set action date of April 29, 2017 under prescription drug 
user fee act 
 
Source text for Eikon:  urn:newsml:reuters.com:*:nBw6G6pjTa 
Further company coverage:  ARIA.O  
 
 ((Bangalore.newsroom@thomsonreuters.com;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.